NOVA CJC-1295

CJC-1295, also known as DAC:GRF, is a synthetic analogue of growth hormone-releasing hormone and a growth hormone secretagogue which was developed by ConjuChem Biotechnologies. It is a modified form of GHRH with improved pharmacokinetics, especially in regard to half-life.